Education
About Us
Working with TipRanks
Follow Us
Precision BioSciences (DTIL)
NASDAQ:DTIL
Total Valuation
Precision BioSciences has a market cap or net worth of $140.20M. The enterprise value is -$36.58M.
Market Cap$140.20M
Enterprise Value-$36.58M
Share Statistics
Precision BioSciences has 24,726,694 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,726,694
Owned by Insiders2.76%
Owned by Institutions37.97%
Financial Efficiency
Precision BioSciences’s return on equity (ROE) is -0.50 and return on invested capital (ROIC) is -35.47%.
Return on Equity (ROE)-0.50
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-35.47%
Return on Capital Employed (ROCE)-0.36
Revenue Per Employee317.26K
Profits Per Employee-423.37K
Employee Count108
Asset Turnover0.22
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Precision BioSciences is ―. Precision BioSciences’s PEG ratio is 0.00266.
PE Ratio―
PS Ratio1.56
PB Ratio0.58
Price to Fair Value0.58
Price to FCF-0.81
Price to Operating Cash Flow-1.10
PEG Ratio0.00266
Income Statement
In the last 12 months, Precision BioSciences had revenue of 34.26M and earned -45.72M in profits. Earnings per share was -3.56.
Revenue34.26M
Gross Profit31.51M
Operating Income-52.15M
Pretax Income-46.61M
Net Income-45.72M
EBITDA-46.61M
Earnings Per Share (EPS)-3.56
Cash Flow
In the last 12 months, operating cash flow was -65.84M and capital expenditures -350.00K, giving a free cash flow of -66.19M billion.
Operating Cash Flow-65.84M
Free Cash Flow-66.19M
Free Cash Flow per Share-2.68
Dividends & Yields
Precision BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change12.28%
50-Day Moving Average4.18
200-Day Moving Average4.93
Relative Strength Index (RSI)72.26
Average Volume (3m)220.07K
Important Dates
Precision BioSciences upcoming earnings date is May 13, 2026, TBA (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Precision BioSciences as a current ratio of 13.32, with Debt / Equity ratio of 1.63%
Current Ratio13.32
Quick Ratio13.32
Debt to Market Cap0.45
Net Debt to EBITDA2.35
Interest Coverage Ratio-36.67
Taxes
In the past 12 months, Precision BioSciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Precision BioSciences EV to EBITDA ratio is 1.20, with an EV/FCF ratio of 0.85.
EV to Sales-1.63
EV to EBITDA1.20
EV to Free Cash Flow0.85
EV to Operating Cash Flow0.85
Balance Sheet
Precision BioSciences has $115.58M in cash and marketable securities with $1.51M in debt, giving a net cash position of $114.08M billion.
Cash & Marketable Securities$115.58M
Total Debt$1.51M
Net Cash$114.08M
Net Cash Per Share$4.61
Tangible Book Value Per Share$7.10
Margins
Gross margin is 94.02%, with operating margin of -152.19%, and net profit margin of -133.45%.
Gross Margin94.02%
Operating Margin-152.19%
Pretax Margin-136.03%
Net Profit Margin-133.45%
EBITDA Margin-136.03%
EBIT Margin-152.19%
Analyst Forecast
The average price target for Precision BioSciences is $36.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$36.33
Price Target Upside540.74% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-99.07%
EPS Growth Forecast-10347.56%